Published in Respiratory Therapeutics Week, September 12th, 2005
According to the poll, awareness of IPF is very low compared to other less prevalent disorders, with less than a third of Americans (29%) knowing anything about the disorder. Forty-four of those familiar with IPF only know its name.
"Public awareness is vital to the fight against IPF," said Mark Shreve, chief executive officer of the CPF. "There is an undeniable correlation between increased public awareness of rare diseases and the amount of resources that are made available to find treatments and cures.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.